Related Experiment Videos
Primary carnitine deficiency: heterozygote and intrafamilial phenotypic variation
B Garavaglia1, G Uziel, F Dworzak
1Division of Biochemistry and Genetics, Istituto Nazionale Neurologico C. Besta, Milano, Italy.
Neurology
|October 1, 1991
Summary
Primary carnitine deficiency presents varied symptoms, impacting muscles and heart differently. Even carriers (heterozygotes) can show cardiac issues, highlighting the condition's complex genetic expression.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Primary carnitine deficiency is an inherited metabolic disorder affecting cellular energy production.
- Carnitine is essential for transporting fatty acids into mitochondria for energy generation.
Observation:
- Two boys from separate families presented with primary carnitine deficiency.
- One boy exhibited cardiomyopathy and myopathy; the other had hypoglycemia and myopathy without cardiomyopathy.
- Carnitine uptake in cultured fibroblasts was significantly reduced in both patients.
Findings:
- Reduced Vmax for carnitine transport was observed in parents and a sibling of the first patient.
- A sibling of the second patient died with dilated cardiomyopathy and low cardiac carnitine levels.
- Autosomal recessive primary carnitine deficiency demonstrates variable phenotypic expression within and between families.
Implications:
- Carnitine deficiency can lead to severe cardiac and muscle complications.
- Heterozygotes for primary carnitine deficiency may exhibit cardiac involvement.
- Understanding the variable expressivity is crucial for accurate diagnosis and genetic counseling.